Anthony Palumbo and Charles Goulding analyze Boston Scientific’s US$14.5 billion acquisition of Penumbra, showing how additive manufacturing can accelerate thrombectomy and neurovascular innovation through rapid device prototyping, micro-precision component development, production tooling, and the use of 3D printed vascular models for testing and physician training.
boston scientific
From Pulsed Energy to Printed Anatomy: 3D Printing’s Role in Modern EP
Charles R. Goulding and Andress Bonafe break down how Boston Scientific and Johnson & Johnson’s EP rivalry is fueling explosive PFA growth and a surge in demand for 3D printed cardiac models.
How 3D Printing Propelled Medical Device Giants Boston Scientific, Edwards Lifesciences, Stryker, and Medtronic
Charles R. Goulding and Mwansa Chabala look at how four medtech companies leveraged 3D printing to recover after the pandemic.
Boston Scientific’s 2021 Mergers & Acquisitions and 3D Printing
Charles R. Goulding and Preeti Sulibhavi look at how Boston Scientific has been using 3D printing in the med-tech sector.